Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neural Transm (Vienna) ; 113(1): 87-92, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16372146

RESUMO

In two 4-week polysomnography pilot studies with 10 patients each, we investigated the efficacy of oral lisuride as monotherapy in de novo RLS patients as well as in combination with levodopa in advanced RLS. Daily doses at study end were 0.3 mg lisuride, plus 150 mg levodopa in the combination study. Marked improvements occurred in both studies in different PLM indexes and in the CGI. Levodopa dose could be decreased by 27%. Lisuride might be an efficacious treatment for RLS in general, and in combination with levodopa in advanced stage.


Assuntos
Levodopa/administração & dosagem , Lisurida/administração & dosagem , Síndrome das Pernas Inquietas/tratamento farmacológico , Adulto , Idoso , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Polissonografia/efeitos dos fármacos , Síndrome das Pernas Inquietas/fisiopatologia , Método Simples-Cego
2.
J Neural Transm (Vienna) ; 109(2): 157-69, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12075855

RESUMO

Dopamine agonists play an important role in the treatment of Parkinson's disease by reducing the administration of L-3,4-dihydroxyphenylalanine (L-DOPA). The enzymatic and non-enzymatic conversion of L-DOPA is suspected to increase oxidative stress, which leads to the degeneration of dopaminergic neurons in Parkinson's disease. In primary mouse mesencephalic cultures we show that the dopamine D1/D2 receptor agonist lisuride, in a concentration range of 0.001-1 microM, enhances the survival of dopaminergic neurons, protects against toxicity induced by L-DOPA or 1-methyl-4-phenylpyridinium ion (MPP+) and stimulates 3H-dopamine uptake. Lisuride also reduces anaerobic metabolism during incubation with L-DOPA. The present findings suggest that lisuride may have trophic/survival-promoting properties and potentially reduces oxidative stress.


Assuntos
Antiparkinsonianos/farmacologia , Citoproteção , Dopamina/fisiologia , Lisurida/farmacologia , Neurônios/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , 1-Metil-4-fenilpiridínio/toxicidade , Animais , Antiparkinsonianos/toxicidade , Células Cultivadas , Levodopa/toxicidade , Mesencéfalo/efeitos dos fármacos , Mesencéfalo/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Neurônios/metabolismo
4.
Child Abuse Negl ; 6(2): 129-39, 1982.
Artigo em Inglês | MEDLINE | ID: mdl-6892293

RESUMO

This article examines a multifactorial model of causes and consequences of harsh parental punishment. The social-psychological model as developed by Gelles was extended to also include the antecedent conditions leading to rigid assertion of parental power relating to the child. Furthermore, personality problems of the child observable as consequences of harsh parental punishment were included in our model. The conditions which predict harsh parental punishment are--in the rank order of their importance: a child perceived as difficult to handle, i.e., a "problem child"; parental anger-proneness; the rigid assertion of parental power; and intra-familial problems and conflicts. As consequences of harsh parental punishment and rejection as perceived by the child, two types of personality problems were observed: a syndrome named "Conduct Disorder" and a syndrome including personality problems such as anxiety and helplessness.


Assuntos
Pais , Punição , Criança , Maus-Tratos Infantis , Alemanha Ocidental , Humanos , Modelos Teóricos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...